Qiuwen Peng

With the full implementation of the DRG/DIP payment reform, the commercial health insurance market is expected to see development opportunities for middle-market medical insurance.

With regulatory guidance and promotion of LTC conversion business in China, insurers can capitalize on opportunities, but need to understand the risks.

中国におけるLTC転換契約に関する監督当局ガイダンスとその推進について、保険会社は、この機会を利用することが可能ですが、そのリスクについて理解する必要があります。

アジアの市場における長期介護（LTC）の進展、ミリマンのLTC Advanced Risk Analytics、また今後の調査報告など、LTCの現行プロジェクトについてお伝えします。

We review current projects in long-term care (LTC), such as LTC development in Asian market, Milliman LTC Advanced Risk Analytics, and upcoming studies.

What is the current status of telehealth in major geographic markets, including the US, Europe and Asia?

Local strategies differ when it comes to fighting COVID-19, and it’s too early to know which strategy- contain or delay- works better.

This article investigates the transition from the currently mainstream fee-for-service model to the diagnosis-related group (DRG) payment model, the history of DRG in foreign markets, and the potential challenges to having a DRG payment model in China’s system.

本稿では、現在の主流である出来高払いの診療報酬モデルから診断別疾病分類（DRG）支払モデルへの移行、諸外国でのDRGの歴史、そして中国の制度としてDRG支払モデルを取り入れる潜在的課題について検討します。

This article discusses the rising trend of loss ratios for Million Medical products, the underlying driving force behind the trend, and the potential management measures to be undertaken by insurers to mitigate such risk.